Hunter Holmes Mcguire Veteran Affairs Medical Center
37
3
4
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.4%
2 terminated/withdrawn out of 37 trials
93.3%
+6.8% vs industry average
11%
4 trials in Phase 3/4
18%
5 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (37)
Cryotherapy for Locally Advanced Esophageal Cancer
Role: lead
Cryotherapy for Malignant Dysphagia in Patients With Advanced Esophageal Cancer
Role: lead
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
Role: lead
Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement
Role: lead
Longitudinal Monitoring of Stool Characteristics
Role: lead
Effect of Brief Dietary Intervention on Ammonia Levels
Role: lead
Oral Health In Cirrhosis of the Liver (ORACLE)
Role: lead
Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction
Role: lead
Vagal Nerve Stimulation as an Alternative Therapy for Premature Ventricular Contractions
Role: lead
Longitudinal Monitoring of Inflammation in Cirrhosis
Role: lead
Feasibility and Efficacy of A Yoga Intervention for Comorbid Chronic Pain and PTSD
Role: lead
Rifamycin in Minimal Hepatic Encephalopathy
Role: lead
HEAL STUDY (Hepatic Encephalopathy and Albumin Study)
Role: lead
Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation
Role: lead
Postoperative Peripheral Nerve Stimulation for Management of Post-amputation Pain
Role: lead
Bassini Inguinal Hernia Repair: Obsolete Or Still A Viable Surgical Option?
Role: lead
Prospective Assessment of Premature Ventricular Contractions Suppression in Cardiomyopathy(PAPS)
Role: lead
rTMS for Cognitive Rehabilitation After TBI
Role: lead
Rifaximin in Minimal Hepatic Encephalopathy
Role: lead
Fecal Microbial Transplant for Alcohol Misuse in Cirrhosis
Role: lead